The supplemental Biologics License Application for the gastric/GEJ cancer indication is supported by data from the double-blind, placebo-controlled MATTERHORN trial.

A PedCST designed for pediatric oncology nurses and an interactive e-picture book application for pediatric patients and their parents improved QOL and emotional well-being for children with cancer.

These findings suggest a need to investigate whether age-specific trends are due to guidelines that suggest reduced screening for older age groups,” the researchers wrote.

Robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty is feasible, with acceptable complication rates.

The authors concluded that even mild 18 F-FDG uptake may indicate the presence of lymphoma in areas of the brain where the blood-brain barrier is intact. They recommended clinicians be suspicious of ...

A retrospective assessment of patient records identified common oral complications of radiotherapy and chemoradiotherapy for head and neck cancers.

Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.

Topline data were announced from a phase 3 trial evaluating zanzalintinib in combination with atezolizumab in patients with previously treated non-microsatellite instability (MSI)-high metastatic ...

Our trial provides proof of concept that cytokine-armored CAR T-cell treatment is feasible and may enhance antitumor activity without additional toxic effects,” researchers reported.

The survey was conducted in May 2025 online (978 participants) and by telephone (30 participants).

A review of the literature revealed that immune effector cell-associated neurotoxicity syndrome (ICANS) is a common adverse effect of CAR-T therapy.

Venetoclax-based regimens showed a trend toward improved survival compared to BTK inhibitors, although subgroup sizes were small.